$ANAC Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Anacor Pharmaceuticals, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Anacor Pharmaceuticals, Inc.. Get notifications about new insider transactions in Anacor Pharmaceuticals, Inc. for free.
Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
---|---|---|---|---|---|---|---|---|---|---|---|
May 24 2011 | ANAC | Anacor Pharmaceuti ... | Parker Geoffrey M. | Sr. V.P. & CFO | Buy | P | 5.99 | 2,500 | 14,975 | 22,500 | 20 K to 22.5 K (+12.50 %) |
May 11 2011 | ANAC | Anacor Pharmaceuti ... | Parker Geoffrey M. | Senior Vice Preside ... | Buy | P | 6.35 | 2,800 | 17,780 | 20,000 | 17.2 K to 20 K (+16.28 %) |
May 11 2011 | ANAC | Anacor Pharmaceuti ... | Parker Geoffrey M. | Senior Vice Preside ... | Buy | P | 6.33 | 100 | 633 | 17,200 | 17.1 K to 17.2 K (+0.58 %) |
May 11 2011 | ANAC | Anacor Pharmaceuti ... | Parker Geoffrey M. | Senior Vice Preside ... | Buy | P | 6.27 | 900 | 5,643 | 17,100 | 16.2 K to 17.1 K (+5.56 %) |
May 11 2011 | ANAC | Anacor Pharmaceuti ... | Parker Geoffrey M. | Senior Vice Preside ... | Buy | P | 6.20 | 2,500 | 15,500 | 16,200 | 13.7 K to 16.2 K (+18.25 %) |
May 11 2011 | ANAC | Anacor Pharmaceuti ... | Parker Geoffrey M. | Senior Vice Preside ... | Buy | P | 6.18 | 2,700 | 16,686 | 13,700 | 11 K to 13.7 K (+24.55 %) |
May 11 2011 | ANAC | Anacor Pharmaceuti ... | Parker Geoffrey M. | Senior Vice Preside ... | Buy | P | 6.17 | 600 | 3,702 | 11,000 | 10.4 K to 11 K (+5.77 %) |
May 11 2011 | ANAC | Anacor Pharmaceuti ... | Parker Geoffrey M. | Senior Vice Preside ... | Buy | P | 6.12 | 100 | 612 | 10,400 | 10.3 K to 10.4 K (+0.97 %) |
May 11 2011 | ANAC | Anacor Pharmaceuti ... | Parker Geoffrey M. | Senior Vice Preside ... | Buy | P | 6.11 | 4,490 | 27,434 | 10,300 | 5.8 K to 10.3 K (+77.28 %) |
May 11 2011 | ANAC | Anacor Pharmaceuti ... | Parker Geoffrey M. | Senior Vice Preside ... | Buy | P | 6.10 | 835 | 5,094 | 5,810 | 5 K to 5.8 K (+16.78 %) |
May 11 2011 | ANAC | Anacor Pharmaceuti ... | Parker Geoffrey M. | Senior Vice Preside ... | Buy | P | 6.09 | 4,875 | 29,689 | 4,975 | 100 to 5 K (+4,875.00 %) |
May 11 2011 | ANAC | Anacor Pharmaceuti ... | Parker Geoffrey M. | Senior Vice Preside ... | Buy | P | 6.02 | 100 | 602 | 100 | 0 to 100 |
Apr 04 2011 | ANAC | Anacor Pharmaceuti ... | Hove Anders D | Director | Option Exercise | A | 6.92 | 30,000 | 207,600 | 30,000 | |
Apr 04 2011 | ANAC | Anacor Pharmaceuti ... | Parker Geoffrey M. | Senior Vice Preside ... | Option Exercise | A | 6.92 | 20,300 | 140,476 | 20,300 | |
Apr 04 2011 | ANAC | Anacor Pharmaceuti ... | Shapiro Lucy | Director | Option Exercise | A | 6.92 | 30,000 | 207,600 | 30,000 | |
Apr 04 2011 | ANAC | Anacor Pharmaceuti ... | Plattner Jacob j | Senior VP, Research | Option Exercise | A | 6.92 | 65,100 | 450,492 | 65,100 | |
Apr 04 2011 | ANAC | Anacor Pharmaceuti ... | Maples Kirk R | Senior VP, Program ... | Option Exercise | A | 6.92 | 65,100 | 450,492 | 65,100 | |
Apr 04 2011 | ANAC | Anacor Pharmaceuti ... | KLINGENSTEIN PAUL H | Director | Option Exercise | A | 6.92 | 30,000 | 207,600 | 30,000 | |
Apr 04 2011 | ANAC | Anacor Pharmaceuti ... | LESCHLY MARK | Director | Option Exercise | A | 6.92 | 30,000 | 207,600 | 30,000 | |
Apr 04 2011 | ANAC | Anacor Pharmaceuti ... | Markham Richard J | Director | Option Exercise | A | 6.92 | 30,000 | 207,600 | 30,000 | |
Apr 04 2011 | ANAC | Anacor Pharmaceuti ... | PERRY DAVID P | President and CEO | Option Exercise | A | 6.92 | 185,000 | 1,280,200 | 185,000 | |
Apr 04 2011 | ANAC | Anacor Pharmaceuti ... | Heyman Irwin A | Senior VP, Drug Dev ... | Option Exercise | A | 6.92 | 52,900 | 366,068 | 52,900 | |
Apr 04 2011 | ANAC | Anacor Pharmaceuti ... | RIEFLIN WILLIAM JL | Director | Option Exercise | A | 6.92 | 30,000 | 207,600 | 30,000 | |
Dec 02 2010 | ANAC | Anacor Pharmaceuti ... | Hove Anders D | Director | Option Exercise | C | 0.00 | 139,105 | 0 | 0 | |
Dec 02 2010 | ANAC | Anacor Pharmaceuti ... | Hove Anders D | Director | Option Exercise | C | 0.00 | 133,622 | 0 | 0 | |
Dec 02 2010 | ANAC | Anacor Pharmaceuti ... | Hove Anders D | Director | Option Exercise | C | 0.00 | 1,752,808 | 0 | 0 | |
Dec 02 2010 | ANAC | Anacor Pharmaceuti ... | Hove Anders D | Director | Grant | A | 5.00 | 2,000,000 | 10,000,000 | 4,625,535 | 2.6 M to 4.6 M (+76.17 %) |
Dec 02 2010 | ANAC | Anacor Pharmaceuti ... | Hove Anders D | Director | Buy | P | 5.00 | 600,000 | 3,000,000 | 2,625,535 | 2 M to 2.6 M (+29.62 %) |
Dec 02 2010 | ANAC | Anacor Pharmaceuti ... | Hove Anders D | Director | Buy | C | 0.00 | 139,105 | 0 | 2,025,535 | 1.9 M to 2 M (+7.37 %) |
Dec 02 2010 | ANAC | Anacor Pharmaceuti ... | Hove Anders D | Director | Buy | C | 0.00 | 133,622 | 0 | 1,886,430 | 1.8 M to 1.9 M (+7.62 %) |
Dec 02 2010 | ANAC | Anacor Pharmaceuti ... | Hove Anders D | Director | Buy | C | 0.00 | 1,752,808 | 0 | 1,752,808 | 0 to 1.8 M |
Dec 02 2010 | ANAC | Anacor Pharmaceuti ... | VENROCK ASSOCIATES IV L P | 10% Owner | Option Exercise | C | 0.00 | 139,105 | 0 | 0 | |
Dec 02 2010 | ANAC | Anacor Pharmaceuti ... | VENROCK ASSOCIATES IV L P | 10% Owner | Option Exercise | C | 0.00 | 133,622 | 0 | 0 | |
Dec 02 2010 | ANAC | Anacor Pharmaceuti ... | VENROCK ASSOCIATES IV L P | 10% Owner | Option Exercise | C | 0.00 | 1,752,808 | 0 | 0 | |
Dec 02 2010 | ANAC | Anacor Pharmaceuti ... | VENROCK ASSOCIATES IV L P | 10% Owner | Buy | P | 5.00 | 600,000 | 3,000,000 | 2,625,535 | 2 M to 2.6 M (+29.62 %) |
Dec 02 2010 | ANAC | Anacor Pharmaceuti ... | VENROCK ASSOCIATES IV L P | 10% Owner | Buy | C | 0.00 | 139,105 | 0 | 2,025,535 | 1.9 M to 2 M (+7.37 %) |
Dec 02 2010 | ANAC | Anacor Pharmaceuti ... | VENROCK ASSOCIATES IV L P | 10% Owner | Buy | C | 0.00 | 133,622 | 0 | 1,886,430 | 1.8 M to 1.9 M (+7.62 %) |
Dec 02 2010 | ANAC | Anacor Pharmaceuti ... | VENROCK ASSOCIATES IV L P | 10% Owner | Buy | C | 0.00 | 1,752,808 | 0 | 1,752,808 | 0 to 1.8 M |
Dec 02 2010 | ANAC | Anacor Pharmaceuti ... | RHO VENTURES IV QP LP | 10% Owner | Option Exercise | C | 0.00 | 221,235 | 0 | 0 | |
Dec 02 2010 | ANAC | Anacor Pharmaceuti ... | RHO VENTURES IV QP LP | 10% Owner | Option Exercise | C | 0.00 | 212,514 | 0 | 0 | |
Dec 02 2010 | ANAC | Anacor Pharmaceuti ... | RHO VENTURES IV QP LP | 10% Owner | Option Exercise | C | 0.00 | 1,752,807 | 0 | 0 | |
Dec 02 2010 | ANAC | Anacor Pharmaceuti ... | RHO VENTURES IV QP LP | 10% Owner | Option Exercise | C | 0.00 | 400,720 | 0 | 0 | |
Dec 02 2010 | ANAC | Anacor Pharmaceuti ... | RHO VENTURES IV QP LP | 10% Owner | Option Exercise | C | 0.00 | 507,398 | 0 | 0 | |
Dec 02 2010 | ANAC | Anacor Pharmaceuti ... | RHO VENTURES IV QP LP | 10% Owner | Buy | P | 5.00 | 2,400,000 | 12,000,000 | 5,621,423 | 3.2 M to 5.6 M (+74.50 %) |
Dec 02 2010 | ANAC | Anacor Pharmaceuti ... | RHO VENTURES IV QP LP | 10% Owner | Buy | C | 0.00 | 221,235 | 0 | 3,221,423 | 3 M to 3.2 M (+7.37 %) |
Dec 02 2010 | ANAC | Anacor Pharmaceuti ... | RHO VENTURES IV QP LP | 10% Owner | Buy | C | 0.00 | 212,514 | 0 | 3,000,188 | 2.8 M to 3 M (+7.62 %) |
Dec 02 2010 | ANAC | Anacor Pharmaceuti ... | RHO VENTURES IV QP LP | 10% Owner | Buy | C | 0.00 | 1,752,807 | 0 | 2,787,674 | 1 M to 2.8 M (+169.38 %) |
Dec 02 2010 | ANAC | Anacor Pharmaceuti ... | RHO VENTURES IV QP LP | 10% Owner | Buy | C | 0.00 | 527,469 | 0 | 1,034,867 | 507.4 K to 1 M (+103.96 %) |
Dec 02 2010 | ANAC | Anacor Pharmaceuti ... | RHO VENTURES IV QP LP | 10% Owner | Buy | C | 0.00 | 507,398 | 0 | 507,398 | 0 to 507.4 K |
Dec 01 2010 | ANAC | Anacor Pharmaceuti ... | CARE CAPITAL INVESTMENTS II LP | 10% Owner | Option Exercise | C | 0.00 | 107,004 | 0 | 0 | |
Dec 01 2010 | ANAC | Anacor Pharmaceuti ... | CARE CAPITAL INVESTMENTS II LP | 10% Owner | Option Exercise | C | 0.00 | 102,787 | 0 | 0 | |
Dec 01 2010 | ANAC | Anacor Pharmaceuti ... | CARE CAPITAL INVESTMENTS II LP | 10% Owner | Option Exercise | C | 0.00 | 1,348,313 | 0 | 0 | |
Dec 01 2010 | ANAC | Anacor Pharmaceuti ... | CARE CAPITAL INVESTMENTS II LP | 10% Owner | Buy | C | 0.00 | 107,004 | 0 | 1,558,104 | 1.5 M to 1.6 M (+7.37 %) |
Dec 01 2010 | ANAC | Anacor Pharmaceuti ... | CARE CAPITAL INVESTMENTS II LP | 10% Owner | Buy | C | 0.00 | 102,787 | 0 | 1,451,100 | 1.3 M to 1.5 M (+7.62 %) |
Dec 01 2010 | ANAC | Anacor Pharmaceuti ... | CARE CAPITAL INVESTMENTS II LP | 10% Owner | Buy | C | 0.00 | 1,348,313 | 0 | 1,348,313 | 0 to 1.3 M |
Dec 01 2010 | ANAC | Anacor Pharmaceuti ... | Aberdare Ventures II, L.P. | 10% Owner | Option Exercise | C | 0.00 | 99,645 | 0 | 0 | |
Dec 01 2010 | ANAC | Anacor Pharmaceuti ... | Aberdare Ventures II, L.P. | 10% Owner | Option Exercise | C | 0.00 | 95,788 | 0 | 0 | |
Dec 01 2010 | ANAC | Anacor Pharmaceuti ... | Aberdare Ventures II, L.P. | 10% Owner | Option Exercise | C | 0.00 | 593,697 | 0 | 0 | |
Dec 01 2010 | ANAC | Anacor Pharmaceuti ... | Aberdare Ventures II, L.P. | 10% Owner | Option Exercise | C | 0.00 | 256,651 | 0 | 0 | |
Dec 01 2010 | ANAC | Anacor Pharmaceuti ... | Aberdare Ventures II, L.P. | 10% Owner | Option Exercise | C | 0.00 | 324,975 | 0 | 0 | |
Dec 01 2010 | ANAC | Anacor Pharmaceuti ... | Aberdare Ventures II, L.P. | 10% Owner | Buy | P | 5.00 | 300,000 | 1,500,000 | 1,751,936 | 1.5 M to 1.8 M (+20.66 %) |
Dec 01 2010 | ANAC | Anacor Pharmaceuti ... | Aberdare Ventures II, L.P. | 10% Owner | Buy | C | 0.00 | 99,645 | 0 | 1,451,936 | 1.4 M to 1.5 M (+7.37 %) |
Dec 01 2010 | ANAC | Anacor Pharmaceuti ... | Aberdare Ventures II, L.P. | 10% Owner | Buy | C | 0.00 | 95,788 | 0 | 1,352,291 | 1.3 M to 1.4 M (+7.62 %) |
Dec 01 2010 | ANAC | Anacor Pharmaceuti ... | Aberdare Ventures II, L.P. | 10% Owner | Buy | C | 0.00 | 593,697 | 0 | 1,256,503 | 662.8 K to 1.3 M (+89.57 %) |
Dec 01 2010 | ANAC | Anacor Pharmaceuti ... | Aberdare Ventures II, L.P. | 10% Owner | Buy | C | 0.00 | 337,831 | 0 | 662,806 | 325 K to 662.8 K (+103.96 %) |
Dec 01 2010 | ANAC | Anacor Pharmaceuti ... | Aberdare Ventures II, L.P. | 10% Owner | Buy | C | 0.00 | 324,975 | 0 | 324,975 | 0 to 325 K |
Dec 01 2010 | ANAC | Anacor Pharmaceuti ... | LESCHLY MARK | Director | Option Exercise | C | 0.00 | 221,235 | 0 | 0 | |
Dec 01 2010 | ANAC | Anacor Pharmaceuti ... | LESCHLY MARK | Director | Option Exercise | C | 0.00 | 212,514 | 0 | 0 | |
Dec 01 2010 | ANAC | Anacor Pharmaceuti ... | LESCHLY MARK | Director | Option Exercise | C | 0.00 | 1,752,807 | 0 | 0 | |
Dec 01 2010 | ANAC | Anacor Pharmaceuti ... | LESCHLY MARK | Director | Option Exercise | C | 0.00 | 400,720 | 0 | 0 | |
Dec 01 2010 | ANAC | Anacor Pharmaceuti ... | LESCHLY MARK | Director | Option Exercise | C | 0.00 | 507,398 | 0 | 0 | |
Dec 01 2010 | ANAC | Anacor Pharmaceuti ... | LESCHLY MARK | Director | Buy | P | 5.00 | 2,400,000 | 12,000,000 | 5,621,423 | 3.2 M to 5.6 M (+74.50 %) |
Dec 01 2010 | ANAC | Anacor Pharmaceuti ... | LESCHLY MARK | Director | Buy | C | 0.00 | 221,235 | 0 | 3,221,423 | 3 M to 3.2 M (+7.37 %) |
Dec 01 2010 | ANAC | Anacor Pharmaceuti ... | LESCHLY MARK | Director | Buy | C | 0.00 | 212,514 | 0 | 3,000,188 | 2.8 M to 3 M (+7.62 %) |
Dec 01 2010 | ANAC | Anacor Pharmaceuti ... | LESCHLY MARK | Director | Buy | C | 0.00 | 1,752,807 | 0 | 2,787,674 | 1 M to 2.8 M (+169.38 %) |
Dec 01 2010 | ANAC | Anacor Pharmaceuti ... | LESCHLY MARK | Director | Buy | C | 0.00 | 527,469 | 0 | 1,034,867 | 507.4 K to 1 M (+103.96 %) |
Dec 01 2010 | ANAC | Anacor Pharmaceuti ... | LESCHLY MARK | Director | Buy | C | 0.00 | 507,398 | 0 | 507,398 | 0 to 507.4 K |
Dec 01 2010 | ANAC | Anacor Pharmaceuti ... | Shapiro Lucy | Director | Option Exercise | C | 0.00 | 800 | 0 | 0 | |
Dec 01 2010 | ANAC | Anacor Pharmaceuti ... | Shapiro Lucy | Director | Option Exercise | C | 0.00 | 14,450 | 0 | 0 | |
Dec 01 2010 | ANAC | Anacor Pharmaceuti ... | Shapiro Lucy | Director | Option Exercise | C | 0.00 | 16,853 | 0 | 0 | |
Dec 01 2010 | ANAC | Anacor Pharmaceuti ... | Shapiro Lucy | Director | Option Exercise | C | 0.00 | 12,729 | 0 | 0 | |
Dec 01 2010 | ANAC | Anacor Pharmaceuti ... | Shapiro Lucy | Director | Buy | C | 0.00 | 800 | 0 | 397,416 | 396.6 K to 397.4 K (+0.20 %) |
Dec 01 2010 | ANAC | Anacor Pharmaceuti ... | Shapiro Lucy | Director | Buy | C | 0.00 | 14,450 | 0 | 396,616 | 382.2 K to 396.6 K (+3.78 %) |
Dec 01 2010 | ANAC | Anacor Pharmaceuti ... | Shapiro Lucy | Director | Buy | C | 0.00 | 16,853 | 0 | 36,248 | 19.4 K to 36.2 K (+86.89 %) |
Dec 01 2010 | ANAC | Anacor Pharmaceuti ... | Shapiro Lucy | Director | Buy | C | 0.00 | 12,729 | 0 | 19,395 | 6.7 K to 19.4 K (+190.95 %) |
Dec 01 2010 | ANAC | Anacor Pharmaceuti ... | Markham Richard J | Director | Option Exercise | C | 0.00 | 107,004 | 0 | 0 | |
Dec 01 2010 | ANAC | Anacor Pharmaceuti ... | Markham Richard J | Director | Option Exercise | C | 0.00 | 102,787 | 0 | 0 | |
Dec 01 2010 | ANAC | Anacor Pharmaceuti ... | Markham Richard J | Director | Option Exercise | C | 0.00 | 1,348,313 | 0 | 0 | |
Dec 01 2010 | ANAC | Anacor Pharmaceuti ... | Markham Richard J | Director | Buy | C | 0.00 | 107,004 | 0 | 1,558,104 | 1.5 M to 1.6 M (+7.37 %) |
Dec 01 2010 | ANAC | Anacor Pharmaceuti ... | Markham Richard J | Director | Buy | C | 0.00 | 102,787 | 0 | 1,451,100 | 1.3 M to 1.5 M (+7.62 %) |
Dec 01 2010 | ANAC | Anacor Pharmaceuti ... | Markham Richard J | Director | Buy | C | 0.00 | 1,348,313 | 0 | 1,348,313 | 0 to 1.3 M |
Dec 01 2010 | ANAC | Anacor Pharmaceuti ... | KLINGENSTEIN PAUL H | Director | Option Exercise | C | 0.00 | 99,645 | 0 | 0 | |
Dec 01 2010 | ANAC | Anacor Pharmaceuti ... | KLINGENSTEIN PAUL H | Director | Option Exercise | C | 0.00 | 95,788 | 0 | 0 | |
Dec 01 2010 | ANAC | Anacor Pharmaceuti ... | KLINGENSTEIN PAUL H | Director | Option Exercise | C | 0.00 | 593,697 | 0 | 0 | |
Dec 01 2010 | ANAC | Anacor Pharmaceuti ... | KLINGENSTEIN PAUL H | Director | Option Exercise | C | 0.00 | 256,651 | 0 | 0 | |
Dec 01 2010 | ANAC | Anacor Pharmaceuti ... | KLINGENSTEIN PAUL H | Director | Option Exercise | C | 0.00 | 324,975 | 0 | 0 | |
Dec 01 2010 | ANAC | Anacor Pharmaceuti ... | KLINGENSTEIN PAUL H | Director | Option Exercise | C | 0.00 | 4,048 | 0 | 0 | |
Dec 01 2010 | ANAC | Anacor Pharmaceuti ... | KLINGENSTEIN PAUL H | Director | Option Exercise | C | 0.00 | 3,821 | 0 | 0 | |
Dec 01 2010 | ANAC | Anacor Pharmaceuti ... | KLINGENSTEIN PAUL H | Director | Option Exercise | C | 0.00 | 23,688 | 0 | 0 | |
Dec 01 2010 | ANAC | Anacor Pharmaceuti ... | KLINGENSTEIN PAUL H | Director | Option Exercise | C | 0.00 | 10,240 | 0 | 0 | |
Dec 01 2010 | ANAC | Anacor Pharmaceuti ... | KLINGENSTEIN PAUL H | Director | Option Exercise | C | 0.00 | 12,966 | 0 | 0 | |
Dec 01 2010 | ANAC | Anacor Pharmaceuti ... | KLINGENSTEIN PAUL H | Director | Buy | P | 5.00 | 300,000 | 1,500,000 | 1,751,936 | 1.5 M to 1.8 M (+20.66 %) |
Dec 01 2010 | ANAC | Anacor Pharmaceuti ... | KLINGENSTEIN PAUL H | Director | Buy | C | 0.00 | 99,645 | 0 | 1,451,936 | 1.4 M to 1.5 M (+7.37 %) |
Dec 01 2010 | ANAC | Anacor Pharmaceuti ... | KLINGENSTEIN PAUL H | Director | Buy | C | 0.00 | 95,788 | 0 | 1,352,291 | 1.3 M to 1.4 M (+7.62 %) |
Dec 01 2010 | ANAC | Anacor Pharmaceuti ... | KLINGENSTEIN PAUL H | Director | Buy | C | 0.00 | 593,697 | 0 | 1,256,503 | 662.8 K to 1.3 M (+89.57 %) |
Dec 01 2010 | ANAC | Anacor Pharmaceuti ... | KLINGENSTEIN PAUL H | Director | Buy | C | 0.00 | 337,831 | 0 | 662,806 | 325 K to 662.8 K (+103.96 %) |
Dec 01 2010 | ANAC | Anacor Pharmaceuti ... | KLINGENSTEIN PAUL H | Director | Buy | C | 0.00 | 324,975 | 0 | 324,975 | 0 to 325 K |
Dec 01 2010 | ANAC | Anacor Pharmaceuti ... | KLINGENSTEIN PAUL H | Director | Buy | C | 0.00 | 4,048 | 0 | 58,001 | 54 K to 58 K (+7.50 %) |
Dec 01 2010 | ANAC | Anacor Pharmaceuti ... | KLINGENSTEIN PAUL H | Director | Buy | C | 0.00 | 3,821 | 0 | 53,953 | 50.1 K to 54 K (+7.62 %) |
Dec 01 2010 | ANAC | Anacor Pharmaceuti ... | KLINGENSTEIN PAUL H | Director | Buy | C | 0.00 | 23,688 | 0 | 50,132 | 26.4 K to 50.1 K (+89.58 %) |
Dec 01 2010 | ANAC | Anacor Pharmaceuti ... | KLINGENSTEIN PAUL H | Director | Buy | C | 0.00 | 13,478 | 0 | 26,444 | 13 K to 26.4 K (+103.95 %) |
Dec 01 2010 | ANAC | Anacor Pharmaceuti ... | KLINGENSTEIN PAUL H | Director | Buy | C | 0.00 | 12,966 | 0 | 12,966 | 0 to 13 K |
Nov 24 2010 | ANAC | Anacor Pharmaceuti ... | GLAXOSMITHKLINE PLC | 10% Owner | Buy | P | 5.00 | 1,000,000 | 5,000,000 | 2,771,374 | 1.8 M to 2.8 M (+56.45 %) |